The Action of Secretin, Trypsin and Histamine on the Motility of Canine Intestinal Villi

Nemeth, Eva P.; Ihasz, M.; Folly, G.; Papp, M.
December 1973
American Journal of Gastroenterology;Dec1973, Vol. 60 Issue 6, p607
Academic Journal
Gradually increasing doses of secretin, trypsin and histamine were injected into the artery of the first jejunal loop of groups of dogs to determine the number of villous contractions and to study the early capillary effects as well as that upon the jejunal mucous membrane. Secretin significantly increased and trypsin reduced the number of intestinal villous contractions. Histamine increased it when given in a dose lower than 1 µg. and reduced it when a 1 µg. dose was administered, Larger doses of secretin, or trypsin, or histamine elicited spastic contractions of the intestinal villi. In the villi and in the intestinal mucous membrane these agents gave rise to ischemia, dilated the blood capillaries, caused stasis in them and produced pericapillary bleeding. Both in manifestation and in extent this early vascular reaction greatly resembled the impairment of the microcircolation in the mucous membrane seen in experimentally-induced pancreatitis. It is suggested that secretin, trypsin and histamine may inhibit the motor function of the stomach and jejunum in acute pancreatitis.


Related Articles

  • EFFECT OF ALCOHOL ON TRYPSIN INHIBITING CAPACITY IN PANCREATIC JUICE. Elmslie, R.G.; Rao, M. Mohan // Australian Journal of Experimental Biology & Medical Science;Apr1972, Vol. 50 Issue 2, p217 

    Examines the effect of alcohol on the trypsin inhibiting capacity of pancreatic juice secreted in the intact anesthesized dog following the administration of four units of secretin per kilogram (kg) per hour for one hour and two units secretin per kg per hour for six hours. Study of the...

  • Secretin in Children with Autistic Disorder: A Double-Blind, Placebo-Controlled Trial. Handen, Benjamin; Hofkosh, Dena // Journal of Developmental & Physical Disabilities;Jun2005, Vol. 17 Issue 2, p95 

    A number of recent studies have examined the efficacy of secretin (a polypeptide neurotransmitter) to treat symptoms associated with autism. Initial anecdotal reports indicated significant gains in social relatedness and language. However, recent double-blind studies have documented few...

  • Influence of ghrelin on interdigestive gastrointestinal motility in humans. J. Tack; Depoortere, I.; Bisschops, R.; Delporte, C.; Coulie, B.; Meulemans, A.; Janssens, J.; Peeters, T. // Gut;Mar2006, Vol. 55 Issue 3, p327 

    Background: Recent studies in animals have shown that ghrelin stimulates upper gastrointestinal motility through the vagus and enteric nervous system. The aim of the present study therefore was to simultaneously investigate the effect of administration of ghrelin on upper gastrointestinal...

  • The relationship between human β-defensin 3 (hBD3) expression and mean histamine concentration in human placental tissue. Szukiewicz, D.; Klimkiewicz, J.; Pyzlak, M.; Szukiewicz, A.; Maslinska, D. // Inflammation Research;Apr2008, Vol. 57 Issue 0, p69 

    The article presents information on research related to relationship between human defensin and hestamine concentration in placental tissue. Human defensin are peptides and participates in antimicrobial activities. The article highlights the materials and methods for research including...

  • The Gastrointestinal Hormones, Secretin and Cholecystokinin-Pancreozymin. Jorpes, J. Erik; Mutt, Viktor // Annals of Internal Medicine;Sep61, Vol. 55 Issue 3, p395 

    Discusses the history of the gastrointestinal hormones. Strength of the clinical unit of secretin; Clinical use of cholecystokinin; Combined cholecystokinin secretin test.

  • Secretin and Autism: A Two-Part Clinical Investigation. Chez, Michael G.; Buchanan, Cathleen P.; Bagan, Bradley T.; Hammer, Michael S.; McCarthy, Karla S.; Ovrutskaya, Irina; Nowinski, Caralynn V.; Cohen, Zamia S. // Journal of Autism & Developmental Disorders;Apr2000, Vol. 30 Issue 2, p87 

    Recent anecdotal reports have touted the gastrointestinal (GI) hormone secretin as a treatment modality for autism, though there is little clinical evidence or literature to support its viability. We undertook a two-part clinical trial to investigate these claims. Fifty-six patients (49 boys, 7...

  • Reply Reply to B. Rimland's “Comments on ‘Secretin and Autism: A Two-Part Clinical Investigation’”. Chez, Michael G.; Buchanan, Cathleen P. // Journal of Autism & Developmental Disorders;Apr2000, Vol. 30 Issue 2, p97 

    Responds to criticisms on a study about the use of the gastrointestinal hormone secretin as a treatment modality for autism. Data used in concluding that secretin offers no observable clinical improvement in children with varying degrees of autism severity; Characterization of the patient...

  • Comment Comments on “Secretin and Autism: A Two-Part Clinical Investigation” by M. G. Chez et al. Rimland, Bernard // Journal of Autism & Developmental Disorders;Apr2000, Vol. 30 Issue 2, p95 

    Presents a critique of a study on the use of the gastrointestinal hormone secretin as a treatment modality for autism. Failure of the data presented to support the conclusions reached; Shortcomings of the study; Safety of secretin as a treatment for autism.

  • THE PANCREATIC SECRETIN TEST AS A DIAGNOSTIC AID. Zavela, Dan; Guzzetta, Louis; McNair, Ruth Davis // American Journal of Gastroenterology;Aug1955, Vol. 24 Issue 2, p177 

    Focuses on a research study on the use of the pancreatic secretin test as a diagnostic aid. Duodenal mucosal hormone that stimulates the pancreatic juice and bile; Curve devised by researchers for the purpose of differentiation and was based on determination of the icteric index of duodenal...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics